Development of a bispecific Nanobody anti-F17 fimbria as a potential therapeutic tool.
Protein Expr Purif
; 215: 106411, 2024 Mar.
Article
in En
| MEDLINE
| ID: mdl-38056514
Full text:
1
Database:
MEDLINE
Main subject:
Escherichia coli
/
Escherichia coli Infections
Limits:
Animals
Language:
En
Year:
2024
Type:
Article